Create Account
B
Pfizer Inc.
PFE
NYSE
$50.66 -$1.22-2.35% Volume16,457,888 06/28/2022 4:00PM Eastern Quotes delayed
Recommendation
Buy
Prev Close
$49.07
Avg Vol (90D)
27,370,989
Market Cap
$275.33B
Dividend & Yield
$1.58(3.22%)
52-Week Range
$38.82 - $61.71
P/E (TTM)
11.24
EPS (TTM)
$4.37
My Lists My Alerts
Report
Rating
Reward
A
Excellent
Risk
C
Fair
Rating Factors
Growth Index
Excellent
Efficiency Index
Excellent
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Fair
Dividend Index
Good
Headlines
Company Close Updates: Pfizer Inc. stock outperforms competitors despite losses on the day
6/28/2022 - MarketWatch.com
Pfizer, Moderna to be ready with BA.1-specific COVID boosters
6/28/2022 - Financial Post
This "Bizarre" Chart Is Wrecking The Stock Market
6/28/2022 - ValueWalk
J&J does not plan to update its COVID-19 vaccine
6/28/2022 - MarketWatch.com - GOOG
J&J does not plan to update its COVID-19 vaccine
6/28/2022 - MarketWatch.com - MarketPulse
Company News for Jun 28, 2022
6/28/2022 - Zacks Investment Research
Stony Point Wealth Management Inc. Sells 953 Shares of Pfizer Inc. (NYSE:PFE)
6/28/2022 - Zolmax
Ullmann Wealth Partners Group LLC Purchases 335 Shares of Pfizer Inc. (NYSE:PFE)
6/28/2022 - Ticker Report
GenTrust LLC Takes $585,000 Position in Pfizer Inc. (NYSE:PFE)
6/28/2022 - Ticker Report
Bender Robert & Associates Buys 5,763 Shares of Pfizer Inc. (NYSE:PFE)
6/28/2022 - Zolmax
City Holding Co. Sells 565 Shares of Pfizer Inc. (NYSE:PFE)
6/28/2022 - Ticker Report
Covid Vaccines Targeting Variants Are Weighed for Fall Booster Campaign
6/28/2022 - WSJ.com: US Business
Roivant Sciences teams up with Pfizer to launch Priovant
6/28/2022 - SeekingAlpha.com: All News
Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges
6/28/2022 - MarketWatch.com - GOOG
Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges
6/28/2022 - MarketWatch.com - MarketPulse
Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges
6/28/2022 - Yahoo! Finance: News
Pfizer Inc. (NYSE:PFE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
6/28/2022 - Ticker Report
SevenBridge Financial Group LLC Purchases 89,545 Shares of Pfizer Inc. (NYSE:PFE)
6/28/2022 - Ticker Report
Should You Invest in the Vanguard Health Care ETF (VHT)?
6/28/2022 - Zacks Investment Research
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
6/28/2022 - Business Wire
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
6/28/2022 - Globe Newswire
Domani Wealth LLC Grows Holdings in Pfizer Inc. (NYSE:PFE)
6/28/2022 - Ticker Report
Inspirion Wealth Advisors LLC Acquires 237 Shares of Pfizer Inc. (NYSE:PFE)
6/28/2022 - Zolmax
Pfizer (NYSE:PFE) Given a $52.00 Price Target at Barclays
6/28/2022 - Ticker Report
The Depopulation Of Taiwan
6/28/2022 - Zero Hedge
Income Statement
Total Revenue (TTM)
$92.37B
EBITDA (TTM)
$37.32B
EBIT (TTM)
$32.26B
Net Income (TTM)
$24.97B
Balance Sheet
Total Assets (Q)
$183.84B
Total Debt (Q)
$36.44B
Total Liabilities (Q)
$101.16B
Book Value Per Share (Q)
$14.74
Cash Flow
Cash from Operations (TTM)
$34.58B
Cash from Investing (TTM)
-$20.23B
Cash from Financing (TTM)
-$13.59B
Net Change in Cash (TTM)
$703.00M
Filings
Filing Date
Wednesday, May 11, 2022
Period Date
Thursday, March 31, 2022
Next Filing
Week of Aug 8 and 12 (est)
Price History
Loading...
Beta
0.66
7-Day Total Return
8.29%
30-Day Total Return
4.87%
60-Day Total Return
-2.65%
90-Day Total Return
2.18%
Year to Date Total Return
-8.55%
1-Year Total Return
33.97%
2-Year Total Return
66.29%
3-Year Total Return
21.93%
5-Year Total Return
65.80%
52-week Low
Jun 30, 2021 - $38.82
52-week High
Dec 20, 2021 - $61.71
Valuation
Market Cap
$275.33B - Mega Cap
Enterprise Value
$288.13B
Price/Sales (TTM)
3.06
Price/Book (Q)
3.33
Dividends and Shares
Shares Outstanding
5.76B
Dividend Per Share (Most Recent)
$0.40
Dividend Per Share (TTM)
$1.58
Corporate Info
Website
www.pfizer.com
Phone Number
212 733 2323
Address
235 East 42nd Street
New York, NY 10017
Country
United States
Year Founded
1849
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including... more
Weiss Ratings